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Abstract 
 Hughes-Stovin syndrome is a syndrome of unknown etiology characterized by thrombophlebitis and pulmonary 
aneurysms. Less than 40 cases have ever been reported in the English medical literature. We are reporting 
a 38-year-old man with a history of right ventricular thrombus and also deep vein thrombosis who presented 
with massive hemoptysis.
Initial work-up revealed a round opacity on chest roentgenogram which later was diagnosed as a pulmonary 
artery aneurysm on subsequent imaging studies. Based on the history of thrombophlebitis with this newly diag-
nosed pulmonary artery aneurysm a diagnosis of Hughes-Stovin syndrome was made. The patient was treated 
with endovascular coiling of the aneurysm. A sixteen-month follow up was uneventful. To our knowledge, this 
is the first case of HSS ever reported from Iran and the fourth to have a cardiac chambers involvement in the 
course of the disease. 
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Introduction
First described by Drs. John Patterson Hughes and 
Peter George Ingle Stovin in 1959, Hughes-Stovin 
syndrome (HSS) is a rare clinical entity character-
ized by thrombophlebitis and pulmonary aneurysms 
[1, 2]. It is a syndrome of unknown etiology that 
usually affects young men in their second to third 
decade of life presenting with symptoms such as 
cough, dyspnea, hemoptysis, fever and chest pain. 
The expected archetype of the clinical course can 
be categorized into three different phases [3, 4]: 
a) symptoms of thrombophlebitis, b) formation of 
large pulmonary and/or bronchial aneurysms and 
c) aneurysmal rupture leading to massive hemop-
tysis which is the leading cause of mortality in pa-
tients with HSS. We herein are reporting a 38-year- 
-old man with HSS.
Case study
This is a 38-year-old Iranian male patient seen at 
the Pulmonary Diseases Department of our hospital 
in February 2015 with a 40 day history of repeated 
episodes of hemoptysis each about 200 mL with exer-
tional dyspnea, cough, nocturnal fever (not responsive 
to antipyretic medications) and pleuretic chest pain. 
Earlier in 2010, he had been worked up in this hospital 
for acute swelling of left lower limb and upon diagno-
sis of acute deep vein thrombosis (DVT), was put on 
a course of anticoagulation (warfarin). 14 days after the 
initial treatment, acute hemorrhage into the thyroid 
gland occurred and he underwent partial thyroidecto-
my. Since then, he was on levothyroxine and low-dose 
warfarin for about one year with regular follow-ups, 
maintaining INR in therapeutic range. For the first time 
in 2012, he had had episodes of hemoptysis with cough, 
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hemosputum and dyspnea. All initial laboratory tests had 
been within the normal limits. Transthoracic echocardio-
gram (TTE) revealed an echogenic mass lesion measuring 
about 36*20 mm in the right ventricle (RV) attached to 
the interventricular septum adjacent to the inferior vena 
cava (IVC). Subsequent dynamic cardiac MRI with gad-
olinium stipulated the mass as an RV clot (thrombosis). 
Fibroptic bronchoscopy and computerized tomographic 
angiography of the pulmonary arteries (CTA) were unre-
markable. Further laboratory tests including coagulation 
panel, anti-cardiolipin and anti-phospholipid antibodies 
and tests for human immunodeficiency virus 1 and 2, 
hepatitis B surface antigen were normally excepted 
for Factor V Leiden. The patient was commenced on 
intravenous unfractionated heparin followed by 5mgs of 
warfarin daily. A follow-up echocardiography two months 
later revealed no thrombosis. On the current admission, 
the patient was in a good general condition, with nor-
mal vital signs. Physical examination was unremarkable. 
There were no signs of uveitis, oral or genital ulcerations 
or scars of healed genital ulcers. Primary blood tests un-
veiled mild microcytic anemia and a slightly elevated CRP 
(12 mg/L). Coagulation studies were normal (the pa-
tient discontinued warfarin without being told 30 days 
prior to the admission). Plain chest roentgenogram 
divulged a round, well-defined opacity in the right lower 
lobe without air bronchograms (Fig. 1). A consecutive 
contrast-enhanced computed tomography (CECT) of 
thorax affirmed a single fusiform type of aneurysmal dil-
atation of the descending branch of the right pulmonary 
artery (Figs. 2, 3). Further laboratory studies, namely, 
antinuclear antibodies (ANA), anti-dsDNA antibod-
ies, anti-neutrophil cytoplasmic antibodies (cANCA, 
pANCA), complement levels and anticardiolipin anti-
bodies were all within the acceptable range. With this 
newly detected pulmonary artery aneurysm (PAA), an 
indisputable history of thrombophlebitis including both 
the deep veins and cardiac chambers, absence of typi-
cal signs of Behçet’s disease (BD) in a man of this age, 
a diagnosis of Hughes-Stovin syndrome was made. 
In contemplation of the treatment options based on 
the literature, regarding massive hemoptysis and the 
Figure 1. Standard posteroanterior chest X-ray showing 
a round opacity in the right lower lobe
Figure 2. Contrast-enhanced computed tomography (CECT) 
of the chest, axial view showing aneurysmal dilatation of the 
descending branch of the right pulmonary artery with intramu-
ral thrombus formation
Figure 3. Coronal multiplanar reformat (MPR) image showing 
the aneurysm with a round opacity in the right lower lobe
22
Acta Angiol, 2017, Vol. 23, No. 1
www.journals.viamedica.pl/acta_angiologica
singular PAA, an interventional approach was preferred 
because of lower procedural risk and higher chance to 
get effective access to bleeding site with guidance of 
preprocedural CT angiography.
After insertion of 7F short sheath at both right and 
left femoral veins, two diagnostic catheters including 
pigtail and right Judkins were first introduced to pul-
monary artery (Fig. 4) then to right main and lower 
segmental arteries for precise injection and delineating 
the anatomy of aneurysm especially the inflow neck.
For exclusion of the aneurysm, there were some 
alternatives including coil, vascular plug, stent graft 
catheter embolization, etc., but we closed the aneurysm 
easily and effectively with a muscular VSD closure de-
vice, size number 14, using a long 10 F sheath (Fig. 5). 
The thrombosis of aneurysm sac was shown in the 
angiography room by contrast injection using the pigtail 
catheter (Fig. 6). The next day after the procedure, 
CT angiography was repeated which revealed near 
complete thrombosis in the aneurysm and also ex-
tension into the segmental branches which induced 
oligemia in the right lower lobe.
A sixteen-month follow-up was uneventful and the 
patient is doing well now. To our knowledge, this is the 
first HSS patient ever reported from Iran and the fourth 
case to have a cardiac chambers involvement during the 
course of the disease.
Discussion
Hughes-Stovin syndrome was named after two Brit-
ish physicians, John Patterson Hughes and Peter George 
Ingle Stovin who first described the characteristics of 
a syndrome (deep venous thrombosis and pulmonary 
artery aneurysms) in a total of four male patients in 
1959 [1]. Since then, less than forty cases of HSS have 
been reported in the English medical literature [2]. This 
syndrome predominantly affects men in their second 
and third decades of life. The reported cases ranged 
between 12 to 48 years of age [5, 6] but Korunic 
et al. reported a 70-year-old male patient with HSS [7]. 
Only seven women have been reported presenting 
this syndrome thus far [8]. The exact etiology and 
pathogenesis of HSS remains widely unclear. Several 
proposed theories have attempted to explain the 
manifestations of this entity [9, 10]. These encompass 
Figure 4. A pigtail and a right Judkins catheter are introduced 
to the pulmonary artery
 Figure 5. The pulmonary artery aneurysm is closed with a muscular VSD closure device
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infectious causes and angiodysplaisa. Another debatable 
hypothesis accounts for the vascular changes as the 
primary cause which is much closer to the original idea 
proposed by Hughes and Stovin who believed that the 
structural changes in the bronchial arteries impaired 
the provision of adequate nutrition to the pulmonary 
arteries through the vasa vasorum. In turn, these events 
led to inflammation, damage to the elastic tissue and 
creation of arterial aneurysms [1]. Actually, weakening 
of the arterial wall from the subsequent inflammation 
is the likely mechanism [11]. The clinical course of HSS 
can be categorized into three different phases [3, 4]: 
a) symptoms of thrombophlebitis, b) formation of large 
pulmonary and/or bronchial aneurysms and c) aneu-
rysmal rupture leading to massive hemoptysis Patients 
can have seizures, diplopia and cephalalgia secondary 
to raised intracranial pressure consequent to cerebral 
venous sinus thrombosis [1, 12] akin to the patient 
reported by Chalazonitis et al. [13]. About 25% of 
patients with HSS develop thromboembolism, arterial 
aneurysms and vascular occlusions. The distribution of 
the vascular component of the syndrome is as follows: 
arterial (7%), venous (25%) or both (68%) [14]. Some 
authors have proposed that HSS may actually be a par-
tially manifested Behçet’s disease (BD) based on their 
similar findings [12, 15, 16]. In fact, HSS and BD are 
the only vasculitides associated with the development 
of pulmonary artery aneurysms yet most HSS patients 
do not have typical manifestations of BD such as oral 
and genital ulcers, uveitis or arthralgia. The laboratory 
findings in HSS patients are non-specific. The patients 
can have leukocytosis, anemia, raised ESR and elevated 
CRP. As noted earlier, anemia and elevated CRP were 
present in the initial assessment of our patient. Chest 
radiography may reveal round opacities and hilar en-
largement. Helical computed tomography (HCT) and 
magnetic resonance imaging have been reported as 
non-invasive method useful for the diagnosis of PAA [8]. 
Traditionally, conventional angiography has been regard-
ed as a gold standard for the diagnosis of pulmonary 
artery aneurysms [2]. It also aids in assessment of an-
giodysplastic bronchial arteries in HSS. The character-
istic picture seen is aneurysmal formation proximal to 
the occluded segments while distal to the interruption, 
signs of hypoperfusion are observed [17]. However, it 
should be noted that selective pulmonary angiography 
can be hazardous as it carries the risk of aneurysm rup-
ture [18]. Today, in fact, multi-detector row helical CT 
angiography offers more precise visualization of large 
systemic arteries than does conventional angiography [2], 
and is considered the diagnostic method of choice in 
most of the patients. Classic histopathologic findings of 
HSS [1, 2, 12] include diffuse dilatation and partial occlu-
sion of the aneurysmal arteries, perivascular infiltration 
that is predominantly lymphomonocytic and diffuse 
proliferative sclerosis. In the pulmonary veins, fibrosis 
and muscular medial thickening is seen. Due to the lack 
of controlled trials, there are no standard treatment 
guidelines for HSS and various treatment modalities have 
been described in the management of this disease [2]. 
Most commonly, immunosuppressive therapy involv-
ing a combination regimen of glucocorticoids and 
cyclophosphamide has been employed as a first line 
medical management in the treatment of HSS, although 
its effectiveness remains to be fully established [19]. 
Gortani et al. reported successful treatment of re-
fractory HSS with infliximab in a 12-year-old Albanian 
boy [20]. Anticoagulation is generally contraindicated 
due to an increased risk of fatal hemorrhage. However, 
it may be employed with great vigilance in a few careful-
ly evaluated circumstances where the benefits are be-
lieved to significantly outweigh the risks [2]. We decided 
not to restart anticoagulation therapy owing to the 
massive hemoptysis. For the cases of massive hemop-
tysis due to large pulmonary aneurysms or those with 
lesions confined to one segment or one lung (as of our 
case), surgical removal of the aneurysm, interventional 
closure, lobectomy or pneumonectomy can be carried 
out based on the data from published case reports [2]. 
Durieux et al. [21] used surgical intervention for three 
cases of HSS who had isolated pulmonary aneurysms 
and none of them showed any signs of recurrence on 
subsequent follow-ups.
Conclusions
Hughes-Stovin syndrome is a very rare clinical entity. 
Hence the exact etiology is unknown and no widely 
accepted diagnostic criteria have been suggested, the 
Figure 6. The thrombosis of aneurysmal sac is shown after 
contrast
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diagnosis requires a high level of clinical suspicion. Since 
early diagnosis and treatment is the key for improving 
the outcome of HSS patients, having the syndrome in 
mind as a differential diagnosis for PAA, it is imperative 
to consider HSS in the differential diagnosis.
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